Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Arthrotec 75mg/200mcg Modified Release Tablet – PA0822/112/002
- Betnovate RD (Ready Diluted) 0.025% w/w Cream – PA1077/001/004
- Betnovate RD (Ready Diluted) 0.025% w/w Ointment – PA1077/001/005
- Ciprofloxacin 250mg Tablet (20 pack) – PA0749/031/002
- Crystapen 600mcg Powder for Solution for Injection or Infusion – PA0126/313/001
- Innovace 20mg Tablet – PA1286/011/004
- Irbesartan 300mg Tablet – PA0126/205/003
- Isoptin SR 240mg Prolonged Release Tablet – PA2010/003/005
- Nasonex 50mcg/Actuation Nasal Spray – PA1286/038/001
- Osteomel Once Weekly 70mg Tablet – PA0126/148/002
- Pravastatin Teva 10mg Tablet – PA0436/046/001
- Ultiva 2mg Powder for Concentrate for Solution for Infusion – PA1691/032/002
The following shortage has been resolved and supply has resumed to the Irish market:
- Efexor XL 37.5mg Prolonged Release Capsules – PA0822/072/001
- Faverin 50mg Film Coated Tablet – PA2010/031/001
- Fentanyl 100mcg in 2ml Solution for Injection – PA0073/122/001
- Fosavance 70mg/2800IU Tablet – EU/1/05/310/002
- Havrix Monodose Vaccine (Adult) Suspension for Injection in Prefilled Syringe – PA1077/026/002
- Lipantil Supra 145mg Tablet – PA2010/015/003
- Propofol-Lipura 2% 20mg/ml Emulsion for Injection or Infusion – PA0736/018/003
- Septrin Adult 80mg/400mg Oral Solution – PA1691/010/004
- Tevanate Once Weekly 70mg Tablet – PA0749/016/001
- Triapin 5mg/5mg Prolonged Release Tablet – PA0540/082/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.